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The Vpr protein of HIV-1 functions as a vital accessory
gene by regulating various cellular functions including
cell differentiation, apoptosis, NF-κB suppression and cell
cycle arrest of the host cell. Several reports have suggested
that Vpr complexes with the glucocorticoid receptor (GR),
but it remains unclear whether the GR pathway is required
for Vpr's effects. Here we report that Vpr utilizes the GR
pathway as a recruitment vehicle for the NF-κB coactivat-
ing protein Poly(ADP-Ribose) Polymerase-1 (PARP-1).
The glucocorticoid receptor interaction with Vpr is both
necessary and sufficient to facilitate this interaction by
potentiating the formation of a Vpr/GR/PARP-1 complex.
The recruitment of PARP-1 by the Vpr/GR complex pre-
vents its nuclear localization, which is necessary for Vpr to
suppress NF-κB. The association of GR with PARP-1 is not
observed with steroid (glucocorticoid) treatment, suggest-
ing that the GR association with PARP-1 is a gain of func-
tion solely attributed to HIV-1 Vpr. These data provide
important insight into Vpr biology and its role in HIV
pathogenesis.
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